Financial Ratios

SOLARA ACTIVE PHARMA SCIENCES LTD.

NSE : SOLARABSE : 541540ISIN CODE : INE624Z01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE561.7010.05 (+1.82 %)
PREV CLOSE ( ) 551.65
OPEN PRICE ( ) 558.35
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 34817
TODAY'S LOW / HIGH ( )544.35 571.00
52 WK LOW / HIGH ( )287 606.95
NSE560.809.2 (+1.67 %)
PREV CLOSE( ) 551.60
OPEN PRICE ( ) 552.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 560.80 (655)
VOLUME 287023
TODAY'S LOW / HIGH( ) 545.00 572.00
52 WK LOW / HIGH ( )286 606.4
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-6.17-16.2761.5041.9025.75
   CEPS(Rs)24.6414.8591.6476.7857.87
   DPS(Rs)0.000.007.002.005.00
   Book NAV/Share(Rs)417.24423.90442.25368.74332.19
   Tax Rate(%)50.4036.110.000.002.94
Margin Ratios
   Core EBITDA Margin(%)9.286.3423.8319.4115.98
   EBIT Margin(%)3.14-1.2918.8914.4010.87
   Pre Tax Margin(%)-3.10-7.2313.678.514.93
   PAT Margin (%)-1.54-4.6213.678.514.78
   Cash Profit Margin (%)6.144.2120.3615.6010.76
Performance Ratios
   ROA(%)-0.78-2.149.335.483.52
   ROE(%)-1.47-3.7617.1312.198.16
   ROCE(%)1.79-0.6915.2811.5410.39
   Asset Turnover(x)0.510.460.680.640.73
   Sales/Fixed Asset(x)0.800.740.990.921.16
   Working Capital/Sales(x)15.246.905.93-25.23-2069.67
Efficiency Ratios
   Fixed Capital/Sales(x)1.251.351.011.090.86
   Receivable days130.11140.0780.5371.7972.86
   Inventory Days143.29125.2664.8768.1652.85
   Payable days131.69160.25131.34139.64143.73
Valuation Parameters
   PER(x)0.000.0022.6710.5816.28
   PCE(x)13.3344.8015.215.777.24
   Price/Book(x)0.791.573.151.201.26
   Yield(%)0.000.000.500.451.19
   EV/Net Sales(x)1.512.663.351.391.11
   EV/Core EBITDA(x)13.9234.0213.106.486.60
   EV/EBIT(x)48.03-205.7317.749.6710.22
   EV/CE(x)0.771.172.100.860.79
   M Cap / Sales0.821.893.100.900.78
Growth Ratio
   Net Sales Growth(%)13.83-21.5622.33-4.68166.17
   Core EBITDA Growth(%)57.58-76.0545.6621.61251.00
   EBIT Growth(%)376.27-105.3760.4426.26360.90
   PAT Growth(%)62.07-126.5096.4369.54775.33
   EPS Growth(%)62.07-126.4546.7962.72738.09
Financial Stability Ratios
   Total Debt/Equity(x)0.670.670.380.710.63
   Current Ratio(x)1.091.171.350.931.00
   Quick Ratio(x)0.580.630.970.540.67
   Interest Cover(x)0.50-0.223.622.441.83
   Total Debt/Mcap(x)0.850.430.120.590.50

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.